Ingredient disclosure for menstrual products required.
Summary
HF4516 would require manufacturers of menstrual products sold, offered for sale, or distributed in Minnesota to disclose on the outer packaging any intentionally added synthetic ingredients contained in the product. The bill defines “outer product packaging” as the first packaging a consumer sees for a package containing multiple individual products. It applies only to menstrual products with intentionally added synthetic ingredients, and it does not create a separate labeling regime beyond requiring disclosure on the package.
The bill is a consumer-information measure aimed at increasing transparency about the contents of menstrual products. By placing the disclosure requirement on manufacturers, it would affect product labeling practices for items sold in Minnesota and could require companies to revise packaging or distribution practices to ensure compliance. The bill directs enforcement to an existing section of Minnesota law, meaning violations would be handled under the state’s current enforcement framework for related commerce labeling requirements.
Impact
HF4516 would add a new labeling requirement to Minnesota Statutes chapter 325E for menstrual products containing intentionally added synthetic ingredients. Manufacturers would need to disclose those ingredients on the outer packaging of products sold, offered for sale, or distributed in the state. The bill would primarily affect manufacturers, distributors, and retailers of menstrual products by requiring packaging changes and compliance with Minnesota’s existing enforcement provisions under section 325E.3892, subdivision 3.
Sentiment
The available context shows no committee debate or recorded votes, so there is no direct evidence of support or opposition in the materials provided. Based on the bill text and caption, the measure appears to be framed as a straightforward consumer disclosure and product transparency bill, which typically suggests a neutral-to-supportive policy posture. However, without transcripts or vote history, the level of legislative enthusiasm or concern cannot be determined from the record provided.
Contention
No specific points of contention are documented in the provided materials. Potential areas of debate, if raised, would likely involve whether the disclosure requirement is necessary, how broadly “synthetic ingredients” should be understood, the compliance burden on manufacturers, and whether existing labeling rules already provide sufficient consumer information. Because there are no committee transcripts or votes, it is not possible to identify which legislators, stakeholders, or industry groups supported or opposed the bill.
Requirements for products containing lead or cadmium modified, sale of menstrual products containing arsenic or chemicals of high concern prohibited, labeling and testing for menstrual products required, and rulemaking required.